# NCT02323360 (NCT02323360)

> A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02323360
- Phase: NA
- Status: TERMINATED
- Sponsor: Istituto Clinico Humanitas
- Conditions: Hepatocellular Carcinoma
- Interventions: SBRT; TACE
- Enrollment: 41
- Primary outcome: Local control (efficacy of SBRT in selected HCC patients with an incomplete response after TACE/TAE)

## Indexed commentary on NCT02323360 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 4 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct02323360